| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Electron transport chain oxphos system in mitochondria 0.6769737124030423 4.153725204165501 3.271059692844247e-05 0.0192107764173392 0.0193973839785669 54 P14406,O14949,O75306,Q9UDW1,O75438,O43676,O75964,Q7KZN9,P00846,O95298,P21912,P00403,O96000,P22695,O75880,P56385,P24539,P03886,O95167,P13073,Q9Y6M9 21 |
| Nonalcoholic fatty liver disease 0.6651580197362159 3.9141457359380474 9.07248303407826e-05 0.0523805345156353 0.0268999121960423 47 O43676,P14406,Q96GC9,O95167,O96000,Q9P0J0,P22695,O14949,O95298,P13073,P21912,O75306,Q9UDW1,O75438,Q86Y39,Q9Y6M9,P00403 17 |
| Mitochondrial complex i assembly model oxphos system 0.6641411530947998 3.0593073409030915 0.0022184942791141 0.7320697405974932 0.1687010861769468 31 O43676,Q7L592,Q9BUB7,Q9BQ95,O95167,O96000,Q9P0J0,O95298,P03915,O75306,O75438,Q9NPL8,Q9NX14,Q9Y6M9,P03886 15 |
| Oxidative phosphorylation 0.6174727642657112 2.961111276784058 0.0030653116708947 0.8380587204529749 0.1687010861769468 35 O75964,O95167,P00846,O96000,O95298,P03915,O75306,O75438,Q86Y39,P56385,P24539,Q9Y6M9,P03886 13 |
| Alzheimers disease and mirna effects 0.4890558817524597 2.8057886903074025 0.0050193596418892 0.9494086856728884 0.1687010861769468 78 Q9Y277,Q96GC9,P21796,P45880,O95197,P49720,Q96IX5,P07437,P04350,P0DP25,Q8NEB9,Q9UJX6,Q9BVA1,P28072,P49721,Q8NE86,P12236,Q9NQC3,P16615 19 |
| Ferroptosis 0.6621443212766314 2.743575893053735 0.0060773998260406 0.9730802169860574 0.1687010861769468 25 Q9Y277,P48506,P16435,P45880,P48507,Q9NZ45,P09601,Q96QD8 8 |
| Alzheimers disease 0.4731211112195579 2.6393249561201433 0.008307131078175 0.9928932038845736 0.1824492121984371 76 P12236,Q9Y277,P0DP25,Q9NQC3,P21796,P45880,O95197,Q8NEB9,Q9UJX6,Q9BVA1,P28072,P49720,P49721,P16615,P07437,P04350,Q8NE86 17 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.7176176795160337 2.564718494037274 0.0103259543270133 0.9978774236298894 0.2041096971972968 14 P55209,P50402,P42167,O75844,O60725 5 |
| Mitochondrial complex iv assembly 0.777257951132711 2.53894174864676 0.0111188334432112 0.9986803623253924 0.2077084135548665 11 P14406,Q7KZN9,P13073,P00403,Q9Y2R0 5 |
| Ccl18 signaling pathway 0.732604923281498 2.3143053998013845 0.0206509758113615 0.9999957739513116 0.3222639120036157 11 Q86UE4,P08670,P07196,P00403 4 |
| Familial partial lipodystrophy fpld 0.8485771110638012 2.2364168844217507 0.0253244761565873 0.9999997522488552 0.3304339479389032 7 O75844 1 |
| Oxidation by cytochrome p450 0.8525071741623023 2.2272166979578243 0.0259327946748015 0.9999998289076212 0.3304339479389032 6 O43169,P16435,Q16850,Q6UW02 4 |
| Mitochondrial immune response to sarscov2 0.8023922212778569 2.202252151669904 0.027647502035867 0.9999999398169211 0.3304339479389032 8 Q9BQ95,O94826,Q7Z434,Q9Y6M9,Q99623,P35232 6 |
| Mitochondrial complex iii assembly 0.7358429627135729 2.193451765326155 0.0282748461991133 0.9999999589547576 0.3304339479389032 10 P08574,P22695,Q9NVA1,O14949,Q9UDW1,Q6DKK2,Q9Y276 7 |
| Influence of laminopathies on wnt signaling 0.7228866366427639 2.129055128712781 0.0332496995925646 0.9999999980439084 0.3584922156071059 10 O60725,O75844 2 |
| Proteoglycan biosynthesis 0.8752922113517234 2.1128264601796505 0.0346156240408386 0.9999999991542196 0.3637972713000761 5 Q8TB61,Q8NCH0,Q9NX62 3 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.8232856919234989 2.1030507713157833 0.0354613315862335 0.9999999994970228 0.3637972713000761 6 P48506,P07099,P48507,P09601 4 |
| Adipogenesis 0.6216790279611651 2.0687741079907846 0.0385672891951389 0.9999999999257144 0.3688774595599581 15 Q9NZ45,O75844 2 |
| Metapathway biotransformation phase i and ii 0.5740669038943326 2.0327915832729535 0.0420735838461314 0.9999999999914894 0.3960259558850152 22 Q8NCH0,O15217,Q7LGA3,P21964,P07099,Q6UW02 6 |
| Progeriaassociated lipodystrophy 0.664570034315006 1.9599348558559613 0.0500034049531452 0.9999999999999384 0.4249657970924614 11 O75844 1 |
| Glycerophospholipid biosynthetic pathway 0.7733731125280012 1.8869925477962963 0.0591613279940936 0.9999999999999998 0.4440843987404754 6 O00116,O15228,P48651,O95674 4 |
| Glycosylation and related congenital defects 0.7657949445756821 1.8773623972618536 0.0604684415460614 1.0 0.4463175152265197 7 Q9Y5P6,Q9BT22,Q9H0U3,Q13724 4 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.798924150650958 1.7940994202930456 0.0727973015748295 1.0 0.5019627887659759 5 P09601,P48507 2 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.8497951278097804 1.766819182489773 0.0772585151081162 1.0 0.5206170393081012 4 P09601,P48507 2 |
| Cholesterol biosynthesis with skeletal dysplasias 0.7856768021565854 1.7378464845872277 0.0822378674008232 1.0 0.5243769394482602 5 Q15392,Q16850 2 |
| Vitamin d receptor pathway 0.609908925009074 1.6647024686752283 0.0959721302349545 1.0 0.5472257041281543 11 Q5VV42,P20020,Q96KA5,P08183 4 |
| Nrf2are regulation 0.6794672682116176 1.632593940952159 0.1025544264076618 1.0 0.579188331997557 8 P09601,P48507 2 |
| Sphingolipid metabolism in senescence 0.6463716503589821 1.6272957647035324 0.1036742969940327 1.0 0.5799892275232209 9 Q06136,P16278,O15269,Q96G23 4 |
| Ketogenesis and ketolysis 0.7517887295322225 1.5927976879246115 0.1112055839921386 1.0 0.5898897559621906 5 P23786 1 |
| Sphingolipid metabolism overview 0.7014406176918142 1.5888273854402395 0.112099368722677 1.0 0.5898897559621906 7 Q06136,O95470,Q96G23 3 |
| Sphingolipid metabolism integrated pathway 0.7014406176918142 1.5888273854402395 0.112099368722677 1.0 0.5898897559621906 7 Q06136,O95470,Q96G23 3 |
| Sphingolipid pathway 0.6664937928710271 1.5705682995546058 0.1162829581669084 1.0 0.5898897559621906 8 Q06136,O95470,Q96G23 3 |
| Omega3 omega6 fatty acid synthesis 0.7461238078727538 1.5684026235505495 0.116787199233304 1.0 0.5898897559621906 5 O95864,Q15067 2 |
| Amyotrophic lateral sclerosis als 0.6133969052904961 1.56586127190018 0.1173810981509924 1.0 0.5898897559621906 10 Q9BUN8,O96008,P07196 3 |
| Metabolism of spingolipids in er and golgi apparatus 0.9238095238095276 1.533953862997408 0.125041003503509 1.0 0.6046045035612457 3 O95470,Q06136 2 |
| Endothelin pathways 0.6858844244664188 1.5179900752078963 0.1290169006640851 1.0 0.6105615345275576 7 P00403,P16615 2 |
| Kennedy pathway from sphingolipids 0.90918367346939 1.4776997261395393 0.1394881677346886 1.0 0.6266400262626542 3 O95470,Q9UG56 2 |
| Nanomaterial induced apoptosis 0.9030011495379376 1.4539022439042355 0.1459734106260439 1.0 0.6408722429550615 3 Q9NR28 1 |
| Triacylglyceride synthesis 0.7525141123221066 1.3684354148015148 0.1711758252196586 1.0 0.6812568077534068 4 Q9NUQ2,O15228 2 |
| Proximal tubule transport 0.5699897751329036 1.3341562875394914 0.1821526419683028 1.0 0.6968807528206682 10 Q9Y5K8,P05023,P08195,P08183 4 |
| Urea cycle and related diseases 0.8299897993879731 1.2935749255529825 0.1958122881839652 1.0 0.7299934074654053 2 Q9Y619 1 |
| Cellular proteostasis 0.7318815923783577 1.2831377896896858 0.1994438063648336 1.0 0.731105016702625 4 Q9UHV9,O15212,Q99471 3 |
| Eicosanoid synthesis 0.8218293097585905 1.2592581578198156 0.207937101203131 1.0 0.7322157851523317 2 Q9H7Z7 1 |
| Spinal cord injury 0.4759838710672437 1.256856154059535 0.2088057278970525 1.0 0.7322157851523317 18 Q9NQC3,P04083,Q08722,P08670,P62942 5 |
| Omega9 fatty acid synthesis 0.6329842057915481 1.2561140304133451 0.2090746299332275 1.0 0.7322157851523317 6 O95864,P33121 2 |
| Sarscov2 b117 variant antagonises innate immune activation 0.8191091465487916 1.247832111568691 0.2120925463645098 1.0 0.7322157851523317 2 O94826 1 |
| Disorders of folate metabolism and transport 0.6244524060734449 1.2351279343968389 0.2167828945237806 1.0 0.7322157851523317 7 P00374 1 |
| Copper homeostasis 0.6534045385933253 1.1651680237747457 0.2439509863065199 1.0 0.7735985822447395 5 Q9Y6N1,O43819,O75880 3 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.6060024699540767 1.149549215087503 0.2503295853269307 1.0 0.7854256301527509 7 Q15418 1 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.4506031200697169 1.1187503181737115 0.2632466720827868 1.0 0.7921321685738004 20 Q14739,Q15392,O95864,P33121,Q16850,Q14534,Q15800 7 |
| Allograft rejection 0.5464950413220673 1.1147020042713054 0.2649781418608885 1.0 0.7921321685738004 9 P08670 1 |
| Apoptosis modulation and signaling 0.5289411931760779 1.1121127619348454 0.266089670269235 1.0 0.7921321685738004 10 Q9NR28 1 |
| Nuclear receptors metapathway 0.3634028513395619 1.087083160724879 0.2770000591096868 1.0 0.8158379529702169 47 P48506,P50416,O15217,P48507,Q15067,P23786,P09601,Q9H2J7,P08183 9 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.4897670718842232 1.0779795746919192 0.2810428714161896 1.0 0.8179149860634869 12 Q96AY3,P07237,P13674,O15460,Q32P28,O75718 6 |
| Glycerolipids and glycerophospholipids 0.804081632653069 1.0741553225172518 0.2827530727538192 1.0 0.8179149860634869 3 Q9UG56,P48651 2 |
| Neuroinflammation 0.7987901324216337 1.0540495382483392 0.291860237448494 1.0 0.8231722847767133 3 P00403 1 |
| Ppar signaling pathway 0.4612819342138696 1.0319136895215566 0.3021125523593437 1.0 0.830984626916866 14 O95864,P33121,P50416,Q15067,P23786 5 |
| Riboflavin and coq disorders 0.6227652423789126 1.0315671354230196 0.3022749427805538 1.0 0.830984626916866 5 O75208,Q16134 2 |
| Oxidative stress response 0.5779554859573883 1.0193919425344455 0.3080169298829074 1.0 0.8340367096829411 7 P48506,P09601 2 |
| Reninangiotensinaldosterone system raas 0.7843537414966073 0.9994115470626352 0.3175953684189709 1.0 0.8483515922182423 3 Q13555,P0DP25 2 |
| Tryptophan metabolism 0.459299711055087 0.988830062821338 0.3227462928991804 1.0 0.8486952822369738 13 Q15392,P51648,P23381 3 |
| Calcium regulation in cardiac cells 0.4230570334430834 0.987395494561629 0.3234487922184756 1.0 0.8486952822369738 23 P62942,P0DP25,P16615 3 |
| Glycogen synthesis and degradation 0.4470105145893306 0.9728862687466688 0.3306098301905584 1.0 0.85039827228185 15 P52789,P30154,P0DP25,P13807 4 |
| Hepatitis b infection 0.428360900495946 0.9450774942600988 0.3446193142496909 1.0 0.8703214782393578 19 Q9Y277,Q16539,Q16531,P12004,Q7Z434,Q15904 6 |
| Nocgmppkg mediated neuroprotection 0.5916613452098171 0.8969205304384872 0.3697613240426975 1.0 0.8845809308664982 5 Q13555,P07196 2 |
| Purine metabolism 0.5270330254115284 0.8910372130716623 0.3729092066134036 1.0 0.8845809308664982 8 P31939 1 |
| Thermogenesis 0.3894182790261614 0.8308367255438269 0.4060658725560382 1.0 0.9062117146478192 28 P50416,Q15418,P23786 3 |
| Mitochondrial long chain fatty acid betaoxidation 0.4265476965117313 0.8111443429701277 0.4172827834538748 1.0 0.9125926715453252 14 Q9BY49,P22307,P33121,P50416,Q16836,O43772,P23786 7 |
| Camkk2 pathway 0.4581889795580576 0.81028177045344 0.4177782500957023 1.0 0.9125926715453252 11 P09601 1 |
| Pparalpha pathway 0.5287426687175919 0.7927469997322006 0.4279252412103151 1.0 0.9149958326893788 7 P23786 1 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.6089268358987743 0.7806963086287918 0.4349811322211216 1.0 0.9149958326893788 4 P06730,P61201 2 |
| Angiopoietinlike protein 8 regulatory pathway 0.3867934201341069 0.7700057658908599 0.4412964724269179 1.0 0.9149958326893788 26 Q9UPT5,P13807,Q16539,P54619,Q8NEB9,Q15418,O00767,P06730 8 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.5995158302819851 0.7435324161193575 0.4571594033497972 1.0 0.9261985384588424 4 P06730,P49770 2 |
| Nephrotic syndrome 0.4427444758818278 0.7232511356104089 0.4695256077056691 1.0 0.9261985384588424 11 O75844 1 |
| Nrf2 pathway 0.3837583119587047 0.7171043040567971 0.473309740219249 1.0 0.9261985384588424 24 P48506,O15217,P48507,P09601,Q9H2J7 5 |
| Vitamin b12 disorders 0.6977045817922165 0.682288960302564 0.4950562523322319 1.0 0.939721327613902 3 Q96EY8 1 |
| Vitamin dsensitive calcium signaling in depression 0.5058873415309544 0.679138257013614 0.4970502641758265 1.0 0.939721327613902 6 P48506,P20020,Q8NB78 3 |
| Serine metabolism 0.500279084969401 0.6545607790232878 0.5127505830985444 1.0 0.9571983944346608 6 P00374 1 |
| Vitamin a and carotenoid metabolism 0.574106163845445 0.6450093510956014 0.5189211258498796 1.0 0.9608123902239832 4 Q8WTV0 1 |
| Signal transduction through il1r 0.668304863998643 0.5813777006539668 0.5609859231265153 1.0 0.966572262499217 3 Q9BQ95 1 |
| Myometrial relaxation and contraction pathways 0.3776892506415726 0.5794237862794145 0.5623032581344498 1.0 0.966572262499217 17 P0DP25,P16615 2 |
| Steroid biosynthesis 0.6470588235294162 0.5655468360618591 0.5717018769460296 1.0 0.966572262499217 2 Q99829 1 |
| Aryl hydrocarbon receptor pathway wp2586 0.5099160731227063 0.5564925409260377 0.5778741921732649 1.0 0.966572262499217 5 Q16543,O00170,P48506 3 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.4763450557808498 0.5515401313150043 0.5812634641323284 1.0 0.966572262499217 6 Q8TB36,P07196 2 |
| Statin inhibition of cholesterol production 0.5079470512053189 0.5486986975952447 0.5832122401326783 1.0 0.966572262499217 5 Q14534 1 |
| Chromosomal and microsatellite instability in colorectal cancer 0.3762628581367994 0.4786019690924191 0.6322218172548455 1.0 0.9986149253173088 13 Q9UJX6 1 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.6249999880645993 0.4423595882679615 0.6582290173057299 1.0 1.0 3 P08195 1 |
| Glutathione metabolism 0.4457521456686245 0.4300768793036171 0.6671397180187069 1.0 1.0 7 P48507 1 |
| Leukocyteintrinsic hippo pathway functions 0.4431322427308 0.4193777725891102 0.6749400659619038 1.0 1.0 7 Q96GC9 1 |
| Fatty acid betaoxidation 0.3519607212583253 0.4163544289798642 0.6771506697118226 1.0 1.0 18 P50416,P23786 2 |
| Serotonin htr1 group and fos pathway 0.393453801568355 0.3956265197238762 0.6923805701402492 1.0 1.0 10 Q16539,P28482,P27361,P09471,P36507,P63096,P61586,P16220,P04899 9 |
| Thiamine metabolic pathways 0.4974752813463413 0.3720416902177445 0.7098618093899312 1.0 1.0 4 Q9HC21 1 |
| Folate metabolism 0.3536680954720204 0.3631439853250197 0.7164973285702394 1.0 1.0 14 P00374,Q8WTV0 2 |
| Monoamine transport 0.4942206734091046 0.3615395261687598 0.7176961626756699 1.0 1.0 4 Q16539 1 |
| Transsulfuration and onecarbon metabolism 0.3321060507662142 0.2910272866542591 0.7710304505674106 1.0 1.0 18 P48507,O43175,P00374,P48506,P13995 5 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.4090599455040917 0.2866997671451878 0.7743422158982263 1.0 1.0 7 P27361,P42345,P36507,P06730,Q13131,Q96KB5 6 |
| Cardiac hypertrophic response 0.4089206673476269 0.2858700547823642 0.7749776498701453 1.0 1.0 6 Q16539,P27361,P42345,P63000,P36507 5 |
| Onecarbon metabolism 0.3320546879272447 0.2548284047493926 0.7988556355259746 1.0 1.0 15 P00374 1 |
| Vitamin d metabolism 0.5554590733654596 0.2520381331888082 0.801011588966521 1.0 1.0 3 P38435 1 |
| Small cell lung cancer 0.3912155260469729 0.2247202637357524 0.8221968995786648 1.0 1.0 6 Q00534,P11802,P06756,P63208,P05556 5 |
| Mirna regulation of prostate cancer signaling pathways 0.3913487738419575 0.2233517565387351 0.8232617485890872 1.0 1.0 7 Q8NCF5,P28482,P42345,P35222,P36507,P62993 6 |
| Overview of interferonsmediated signaling pathway 0.5280516831009987 0.2173404873789866 0.8279430067378584 1.0 1.0 2 P15260 1 |
| Mapk cascade 0.4087814840027179 0.2029853374099552 0.8391464926963645 1.0 1.0 5 P27361,P36507,P62993,Q16539 4 |
| Phosphodiesterases in neuronal function 0.5261247459243763 0.1870433269194197 0.8516266623864182 1.0 1.0 3 O43924 1 |
| Onecarbon metabolism and related pathways 0.3379691815112731 0.1796624275715562 0.8574175918569 1.0 1.0 11 P48506,P00390,P48507,O43865 4 |
| Ovarian infertility 0.5052703162189834 0.1710028203401759 0.8642215479510686 1.0 1.0 2 Q8WXH0 1 |
| Mecp2 and associated rett syndrome 0.3091482399711875 0.1577684146371356 0.8746392883688161 1.0 1.0 20 P16220,Q96ST3,P35637,Q03518,P31943,P52597 6 |
| Nucleotide metabolism 0.3153265637770051 0.1526232976923088 0.8786953513450633 1.0 1.0 14 P00374 1 |
| Genes related to primary cilium development based on crispr 0.3576889385394614 0.1495796222562437 0.8810962863688441 1.0 1.0 8 O95684 1 |
| Cannabinoid receptor signaling 0.3653139555777323 0.1438205605179026 0.8856421667201557 1.0 1.0 6 Q8NCG7,Q16539 2 |
| Mapk pathway in congenital thyroid cancer 0.4841890513430962 0.1346554652884035 0.8928842859504906 1.0 1.0 2 P36507 1 |
| Bmp signaling in eyelid development 0.4841890513430825 0.1346554652883821 0.8928842859505075 1.0 1.0 2 Q12948 1 |
| Bile acids synthesis and enterohepatic circulation 0.4086423953725828 0.1311978707672203 0.8956187802815758 1.0 1.0 4 P01130,P51114,P27361 3 |
| Serotonin receptor 467 and nr3c signaling 0.4086423953725727 0.1311978707671992 0.8956187802815925 1.0 1.0 4 P27361,P16220,P36507 3 |
| Aryl hydrocarbon receptor pathway wp2873 0.4079618917999399 0.1297686269140702 0.8967494850814277 1.0 1.0 4 Q16543,O00170,P07900 3 |
| Photodynamic therapyinduced ap1 survival signaling 0.3909493024838436 0.0962938007804933 0.9232872344692588 1.0 1.0 4 P07900,P49327,Q16539 3 |
| Purine metabolism and related disorders 0.3045569569903812 0.0922031481436303 0.9265366368451544 1.0 1.0 13 P31939 1 |
| Rala downstream regulated genes 0.3641446490261083 0.0898728733395747 0.9283882378364569 1.0 1.0 5 Q96KP1 1 |
| Wnt signaling in kidney disease 0.4495069704182358 0.0881718009497476 0.9297401295883024 1.0 1.0 2 P61586 1 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.337410213569949 0.0611553655733566 0.9512354762719268 1.0 1.0 7 Q13555 1 |
| Ebsteinbarr virus lmp1 signaling 0.4083645018701145 0.0523073553481335 0.9582837926218596 1.0 1.0 2 P07900 1 |
| Estrogen signaling pathway 0.3515836697045517 0.0354774031912572 0.971699064671304 1.0 1.0 4 Q16539 1 |
| Ras and bradykinin pathways in covid19 0.408503401360549 0.0290917495495749 0.9767914159202262 1.0 1.0 3 P61586,Q99829 2 |
| White fat cell differentiation 0.3182590955457317 0.0228846472310975 0.981742286924392 1.0 1.0 2 P16220 1 |
| Ketone bodies synthesis and degradation 0.2944576674600417 0.0210019151791932 0.983244127921526 1.0 1.0 2 P35914 1 |
| Interactions between loxl4 and oxidative stress pathway 0.334401742215838 0.0159390048702972 0.987283052562434 1.0 1.0 4 Q9BQ95 1 |
| Egfegfr signaling pathway 0.2670962670535748 0.0152969924228167 0.9877952419024234 1.0 1.0 38 O95630,Q16539,Q9P0J0,P12004,Q15418,P00403,O14964,P30086 8 |
| Folatealcohol and cancer pathway hypotheses 0.3739312783231666 0.0100080656383569 0.9920148522444427 1.0 1.0 3 P16220 1 |
| Nitric oxide metabolism in cystic fibrosis 0.3228989452194593 0.0050494935409145 0.9959711041848892 1.0 1.0 4 O14744,O60678,Q86X55 3 |
|
|
